Elicera Therapeutics AB (OSTO:ELIC) Other Long Term Assets : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Elicera Therapeutics AB Other Long Term Assets?

Elicera Therapeutics AB's other long-term assets for the quarter that ended in Mar. 2024 was kr0.00 Mil.

Elicera Therapeutics AB's quarterly other long-term assets increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) but then stayed the same from Dec. 2023 (kr0.00 Mil) to Mar. 2024 (kr0.00 Mil).

Elicera Therapeutics AB's annual other long-term assets declined from Dec. 2021 (kr0.49 Mil) to Dec. 2022 (kr0.48 Mil) and declined from Dec. 2022 (kr0.48 Mil) to Dec. 2023 (kr0.00 Mil).

Elicera Therapeutics AB Other Long Term Assets Historical Data

The historical data trend for Elicera Therapeutics AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elicera Therapeutics AB Other Long Term Assets Chart

Elicera Therapeutics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

0.53

0.48

0.49

0.48

Elicera Therapeutics AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial													0.48	-	-	-	-

Elicera Therapeutics AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Elicera Therapeutics AB (OSTO:ELIC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elicera Therapeutics AB (OSTO:ELIC) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

8E8:Germany

Address

Massans gata 10, World Trade Center Goteborg, 7th Floor, Goteborg, SWE, SE-412 51

Website

https://www.elicera.com

Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments. The company's product portfolio consists of four drug candidates, two in the field of oncolytic viruses (ELC-100 and ELC-201) and two in the field of CAR T-cell treatments (ELC-301 and ELC-401), in addition to a universal CAR T-cell technology platform, iTANK (ELC-001), compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.

Elicera Therapeutics AB (OSTO:ELIC) Headlines

No Headlines